On October 19th, 2021 PERMIT WP6 hosted a virtual workshop on study designs of clinical trials (CTs) for personalised medicine (PM) with 22 stakeholders from the PM research ecosystem. The workshop aimed to develop a single definition of CT for PM, valid for all participants and to identify the specific characteristics of a CT for PM on which future recommendations should focus. In addition, the workshop sought to identify the study designs for assessing a PM vs. non-PM strategy and its attributes. Focus groups will be organized with experts to further discuss some challenges raised during the workshop. Insights and comments of all participants will be used to develop a more advanced version of the recommendations.
EATRIS is proud to be a partner in the #PERMITproject, which has seen another publication (this time in BMJ_Open) that provides a review of the study designs used for #ClinicalTrials in #PersonalisedMedicine. 👉 Find out more about the publication hereatris.eu/news/new-publi…0M0 https://t.co/6AlAFsz2IL
EATRIS is proud to be a partner in the #PERMITproject, which has seen its 2nd review published in the JPM_MDPI titled “Methods for Stratification & Validation Cohorts: A Scoping Review”. 👉 Find out moreeatris.eu/news/new-publi…K#PersonalisedMedicineeECRIN_ERICIN_ERIC https://t.co/MGwVg3uqYV